Immatics N.V. (IMTX)
NASDAQ: IMTX · Real-Time Price · USD
9.37
-0.40 (-4.09%)
Mar 27, 2026, 4:00 PM EDT - Market closed
Immatics Market Cap
Immatics has a market cap or net worth of $1.26 billion as of March 27, 2026. Its market cap has increased by 132.90% in one year.
Market Cap
1.26B
Enterprise Value
723.78M
1-Year Change
132.90%
Ranking
Category
Stock Price
$9.37
Market Cap Chart
Since December 12, 2018, Immatics's market cap has increased from $172.50M to $1.26B, an increase of 628.40%. That is a compound annual growth rate of 31.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 1.26B | -10.74% |
| Dec 31, 2025 | 1.41B | 65.88% |
| Dec 31, 2024 | 848.62M | -4.80% |
| Dec 29, 2023 | 891.43M | 34.26% |
| Dec 30, 2022 | 663.94M | -21.47% |
| Dec 31, 2021 | 845.50M | 24.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 12, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Rapport Therapeutics | 1.33B |
| Savara | 1.30B |
| Precigen | 1.30B |
| Biohaven | 1.26B |
| MoonLake Immunotherapeutics | 1.24B |
| Monte Rosa Therapeutics | 1.23B |
| AtaiBeckley | 1.22B |
| ORIC Pharmaceuticals | 1.21B |